Rifaximin is commonly prescribed for the treatment of Small Intestinal Bacterial Overgrowth (SIBO). SIBO occurs when there’s an abnormal increase in bacteria in the small intestine, leading to various gastrointestinal symptoms such as bloating, abdominal pain, and diarrhea. Rifaximin, being a non-absorbable antibiotic, is thought to target and reduce the overgrowth of bacteria in the small intestine, helping to alleviate these symptoms.
The usual dosage for Rifaximin in the treatment of SIBO is 400 mg taken orally three times a day for a specified duration, typically ranging from 10 to 14 days. It’s important to follow the prescribed dosage and complete the full course of treatment as directed by a healthcare professional.